Login to Your Account

Financings Roundup

Tapestry Collects $25M For Lead Anticancer Compound

By Karen Pihl-Carey

Friday, April 7, 2006
To move its lead cancer product into Phase II trials, Tapestry Pharmaceuticals Inc. closed a $25.5 million private placement with nine institutional investors. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription